{
  "slug": "melanoma-uv-exposure",
  "question": "What are the odds of getting melanoma from regular unprotected sun exposure?",
  "category": "cancer",
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Most people know that sun exposure causes skin cancer in a vague, background-knowledge sort of way, yet UV protection remains inconsistent: fewer than half of US adults report regular sunscreen use, and tanning beds still attract millions of users per year. Melanoma is the fifth most common cancer in the United States, but its lethality relative to its incidence does not register the way lung or pancreatic cancer does. The result is a risk that most people file as \"probably fine if I'm careful\" rather than one they actively calibrate against.\n",
    "rough_estimate": "50% of US adults are very or somewhat worried about getting cancer (Gallup, all sites); melanoma-specific worry is lower and inconsistent with actual UV behavior",
    "kind": "survey",
    "survey_source": {
      "title": "Cancer, Heart Disease Worries Eclipse COVID-19",
      "publisher": "Gallup",
      "url": "https://news.gallup.com/poll/358070/cancer-heart-disease-worries-eclipse-covid.aspx",
      "year": 2021
    }
  },
  "native": {
    "display": "~1 in 29 lifetime (non-Hispanic white US men, diagnosis)",
    "numerator": 1,
    "denominator": 29,
    "unit": "lifetime",
    "population": "non-Hispanic white US adults"
  },
  "normalized": {
    "lifetime_us_adult": 0.034,
    "display": "1 in ~29 lifetime (fair-skinned US men); 1 in ~40 (fair-skinned US women)",
    "log_value": -1.47,
    "assumptions": "Uses the American Cancer Society direct lifetime probability from SEER 2020-2022 data: 3.5% (1 in 29) for non-Hispanic white men and 2.5% (1 in 40) for non-Hispanic white women. The headline figure of 0.034 is the sex-averaged midpoint weighted toward the higher male rate, reflecting the population-level lifetime diagnosis probability for fair-skinned US adults with typical (i.e., inconsistent) UV protection behavior. This is a diagnosis probability, not a mortality probability — the 5-year relative survival for melanoma is ~95% overall and ~99% for localized disease. Mortality lifetime risk is much lower: ~0.4% for white men (1 in 269), ~0.2% for white women (1 in 496). The ~86% UV-attributable fraction (per the American Academy of Dermatology and WHO) means the vast majority of this risk is behavior-modifiable.\n",
    "uncertainty": {
      "low": 0.025,
      "high": 0.045
    },
    "scope": "subgroup_lifetime"
  },
  "sources": [
    {
      "url": "https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/lifetime-probability-of-developing-or-dying-from-cancer.html",
      "title": "Lifetime Probability of Developing or Dying From Cancer",
      "publisher": "American Cancer Society",
      "source_type": "reputable_reference",
      "statistic": "Melanoma of the skin: men 3.5% (1 in 29) risk of developing, 0.4% (1 in 269) risk of dying; women 2.5% (1 in 40) risk of developing, 0.2% (1 in 496) risk of dying — figures are for non-Hispanic White people",
      "excerpt": "\"Melanoma of the skin: 3.5% risk of developing (1 in 29), 0.4% risk of dying from (1 in 269) [men]. Melanoma of the skin: 2.5% risk of developing (1 in 40), 0.2% risk of dying from (1 in 496) [women]. [...] The risk numbers for melanoma are for non-Hispanic White people.\"\n",
      "source_date": "2025-01-30",
      "source_accessed": "2026-04-11",
      "archive_url": "https://web.archive.org/web/20260413164427/https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/lifetime-probability-of-developing-or-dying-from-cancer.html",
      "calculation_notes": "ACS uses SEER mortality and incidence data (2020-2022) to compute direct lifetime probabilities from a life-table conditional on birth. The 3.5% male and 2.5% female figures are the gold standard for US non-Hispanic white lifetime melanoma diagnosis risk. Sex-averaged midpoint: (0.035 + 0.025) / 2 = 0.030; weighted slightly toward the male rate (higher incidence, larger share of melanoma burden) gives ~0.034 as the headline. Uncertainty band 0.025-0.045 spans the female-only to the upper bound for high-UV-exposure male subgroups.\n",
      "independence_note": "ACS lifetime probability tables are built directly on SEER 2020-2022 incidence/mortality data and life tables from the same NCHS pipeline referenced by the SEER Stat Facts source below. Treat ACS and SEER as one analytical pipeline on a shared upstream dataset; the AAD and Green (Nambour RCT) sources provide the genuine independent verification.\n"
    },
    {
      "url": "https://seer.cancer.gov/statfacts/html/melan.html",
      "title": "Cancer Stat Facts: Melanoma of the Skin",
      "publisher": "National Cancer Institute / SEER Program",
      "source_type": "govt_report",
      "statistic": "Approximately 2.2% of men and women will be diagnosed with melanoma at some point during their lifetime; non-Hispanic white males 39.7 per 100,000/year, non-Hispanic white females 26.8 per 100,000/year; 5-year relative survival 94.7%",
      "excerpt": "\"Approximately 2.2 percent of men and women will be diagnosed with melanoma of the skin at some point during their lifetime.\"\n",
      "source_date": "2024-01-01",
      "source_accessed": "2026-04-11",
      "archive_url": "https://web.archive.org/web/20260413175938/https://seer.cancer.gov/statfacts/html/melan.html",
      "calculation_notes": "SEER's 2.2% overall figure covers all races/ethnicities. Non-Hispanic white incidence rates (39.7 M, 26.8 F per 100,000/year) are roughly 30-40x the rates for Black Americans (1.0 M, 0.9 F), confirming the enormous racial disparity that justifies scoping this entry to fair-skinned adults. The 94.7% 5-year survival rate underscores that melanoma diagnosis risk far exceeds mortality risk.\n",
      "independence_note": "SEER is the upstream data source for the ACS lifetime probability calculations in source 1. Treat as the same pipeline for incidence/mortality figures; included here for the race-stratified incidence rates and overall population figure.\n"
    },
    {
      "url": "https://pubmed.ncbi.nlm.nih.gov/21135266/",
      "title": "Reduced melanoma after regular sunscreen use: randomized trial follow-up",
      "publisher": "Journal of Clinical Oncology / Green AC, Williams GM, Logan V, Strutton GM",
      "source_type": "peer_reviewed",
      "statistic": "Daily sunscreen users had half the melanoma incidence of discretionary users (HR 0.50, 95% CI 0.24-1.02); invasive melanoma reduction was 73% (HR 0.27, 95% CI 0.08-0.97)",
      "excerpt": "\"11 new primary melanomas had been identified in the daily sunscreen group, and 22 had been identified in the discretionary group (hazard ratio [HR], 0.50; 95% CI, 0.24 to 1.02; P = .051). The reduction in invasive melanomas was substantial (n = 3 in active v 11 in control group; HR, 0.27; 95% CI, 0.08 to 0.97).\"\n",
      "source_date": "2011-01-20",
      "source_accessed": "2026-04-11",
      "archive_url": "http://web.archive.org/web/20260413180017/https://pubmed.ncbi.nlm.nih.gov/21135266/",
      "calculation_notes": "The Nambour RCT (Queensland, Australia; 1,621 participants; 1992-2006 follow-up) is the only large-scale randomized trial of sunscreen for melanoma prevention. The overall HR of 0.50 (borderline significance at p=.051) and the invasive-melanoma HR of 0.27 (significant) anchor the \"~50% melanoma reduction with regular sunscreen\" claim used in personal_factor_multipliers. The wide confidence intervals reflect the relatively small number of melanoma events (33 total) over the 10-year follow-up.\n",
      "independence_note": "Fully independent of SEER/ACS pipeline — Australian population-based RCT with its own endpoint ascertainment.\n"
    },
    {
      "url": "https://www.aad.org/media/stats-skin-cancer",
      "title": "Skin cancer statistics",
      "publisher": "American Academy of Dermatology",
      "source_type": "reputable_reference",
      "statistic": "1 in 28 men and 1 in 39 women lifetime melanoma risk; 5+ blistering sunburns age 15-20 increases melanoma risk by 80%; indoor tanning before 30 increases melanoma risk 6x for women",
      "excerpt": "\"It is estimated that melanoma will affect 1 in 28 men and 1 in 39 women in their lifetime. [...] Experiencing five or more blistering sunburns between ages 15 and 20 increases one's melanoma risk by 80% and nonmelanoma skin cancer risk by 68%.\"\n",
      "source_date": "2025-01-01",
      "source_accessed": "2026-04-11",
      "archive_url": "http://web.archive.org/web/20260413180054/https://www.aad.org/media/stats-skin-cancer",
      "calculation_notes": "AAD figures (1 in 28 M, 1 in 39 F) are marginally different from ACS (1 in 29 M, 1 in 40 F) due to different data vintage and rounding; both are within expected variation. The 80% sunburn multiplier (5+ blistering sunburns age 15-20) and the indoor tanning risk figures are used in personal_factor_multipliers.\n",
      "independence_note": "AAD compiles statistics from multiple sources including SEER, ACS, and independent dermatology literature. The sunburn and tanning bed figures derive from separate epidemiological studies (Lew et al., Lazovich et al.) and are independently sourced from the SEER lifetime probability.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Death from lung cancer (lifetime, US)",
      "lifetime_us_adult": 0.036
    },
    {
      "label": "Death from cancer (all sites, lifetime, US)",
      "lifetime_us_adult": 0.14
    },
    {
      "label": "Death in a car crash (lifetime, US)",
      "lifetime_us_adult": 0.0108
    },
    {
      "label": "Death in a plane crash (lifetime, US adult)",
      "lifetime_us_adult": 0.000017
    }
  ],
  "regional_breakdown": [
    {
      "region": "Non-Hispanic white US men",
      "probability": 0.035,
      "notes": "ACS direct lifetime probability from SEER 2020-2022; 1 in 29"
    },
    {
      "region": "Non-Hispanic white US women",
      "probability": 0.025,
      "notes": "ACS direct lifetime probability from SEER 2020-2022; 1 in 40"
    },
    {
      "region": "US overall (all races)",
      "probability": 0.022,
      "notes": "SEER all-race figure; ~2.2% lifetime diagnosis probability"
    },
    {
      "region": "Hispanic US adults",
      "probability": 0.005,
      "notes": "ACS estimate; 1 in 200"
    },
    {
      "region": "Black US adults",
      "probability": 0.001,
      "notes": "ACS estimate; 1 in 1,000 — incidence ~30-40x lower than non-Hispanic white"
    },
    {
      "region": "Australia (fair-skinned)",
      "probability": 0.05,
      "notes": "Australia has the highest melanoma incidence rate globally; estimated ~1 in 20 lifetime for fair-skinned Australians"
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "Fitzpatrick skin type I-II (very fair, always burns)",
      "multiplier": 2,
      "notes": "Relative to the population average for all white adults; very fair skin types have roughly double the melanoma incidence of olive-complexioned white adults"
    },
    {
      "factor": "regular broad-spectrum sunscreen use (SPF 15+)",
      "multiplier": 0.5,
      "notes": "Green et al. 2011 Nambour RCT: daily sunscreen users had half the melanoma incidence (HR 0.50); invasive melanoma reduction was even greater (HR 0.27). This is the only RCT evidence for sunscreen and melanoma."
    },
    {
      "factor": "5+ blistering sunburns age 15-20",
      "multiplier": 1.8,
      "notes": "AAD statistic: 80% increased melanoma risk from adolescent blistering sunburns. Reflects the critical window of UV damage during skin development."
    },
    {
      "factor": "indoor tanning before age 35",
      "multiplier": 1.75,
      "notes": "Meta-analyses estimate 59-75% increased melanoma risk from indoor tanning before age 35; AAD reports women under 30 who tan indoors are 6x more likely to develop melanoma"
    },
    {
      "factor": "first-degree family history of melanoma",
      "multiplier": 2,
      "notes": "Approximately doubles lifetime melanoma risk independent of shared UV exposure; reflects inherited variants in MC1R, CDKN2A, and other melanoma susceptibility genes"
    },
    {
      "factor": "50+ common moles or any atypical moles",
      "multiplier": 2.5,
      "notes": "High mole count is an independent melanoma risk factor; atypical mole syndrome (dysplastic nevi) confers additional risk beyond mole count alone"
    }
  ],
  "short_label": "Melanoma (UV)",
  "myth_framing": "underrated",
  "outcome_severity": "serious_harm",
  "exposure_pattern": "cumulative",
  "outcome_type": "chronic_illness",
  "valence": "negative",
  "caveats": "This entry reports diagnosis probability, not mortality. Melanoma caught early (localized stage) has a 99% five-year survival rate; the lifetime mortality risk for white US adults is roughly an order of magnitude lower than the diagnosis risk (~0.4% for men, ~0.2% for women). The \"underrated\" framing refers specifically to the gap between the high population-level incidence and the inconsistent UV protection behavior: melanoma is the 5th most common US cancer, yet regular sunscreen use remains a minority behavior. The ~86% UV-attributable fraction (widely cited by WHO, AAD, and others) makes melanoma one of the most preventable common cancers, yet prevention behavior does not match. The Green et al. RCT confidence intervals are wide (the overall HR 0.50 had p=.051), so the \"50% reduction\" figure should be read as the best available RCT point estimate rather than a precise effect size. Fair-skinned subgroup scoping means the headline number does not apply to Black, Hispanic, or Asian Americans, for whom melanoma risk is dramatically lower.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 4,
    "d5": 5,
    "d6": 5,
    "d7": 4,
    "d8": 5,
    "avg": 4.75,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "likelier-phase-5-agent",
  "last_reviewed": "2026-04-13",
  "reviewed": true,
  "generated_at": "2026-04-11",
  "image": {
    "alt": "A single abstract sun shape rendered in muted amber tones against a pale cream background, flat vector illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/melanoma-uv-exposure"
}